Myles Minter
Stock Analyst at William Blair
(1.96)
# 2,880
Out of 5,152 analysts
25
Total ratings
47.37%
Success rate
3.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Outperform | n/a | $10.95 | - | 3 | Feb 17, 2026 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | n/a | $3.00 | - | 2 | Feb 17, 2026 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $10.31 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $2.00 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $61.43 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $1.11 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.59 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $728.11 | - | 2 | Nov 1, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $7.25 | +879.31% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $53.83 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $460.82 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $310.58 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $5.22 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $320.51 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $75.16 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $129.64 | -10.52% | 1 | Feb 24, 2020 |
Korro Bio
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $10.95
Upside: -
Neumora Therapeutics
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $3.00
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $10.31
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.00
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $61.43
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $1.11
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.59
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $728.11
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $7.25
Upside: +879.31%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $53.83
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $460.82
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $310.58
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $5.22
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $320.51
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $75.16
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $129.64
Upside: -10.52%